Digging Deep for Diabetes Genes
Type 2 diabetes afflicts 7% of Americans and 150 million individuals worldwide. In the simplest case, GWASs would have located 10-20 single-nucleotide polymorphisms (SNPs) in the human genome, with each one contributing 5%-10% of the heritability of type 2 diabetes. Instead, however, eight previous GWASs identified 25 common variations that together account for less than 10% of the overall genetic contribution to this chronic illness. Where is the remaining 90%? One explanation for the missing heritability is that the statistical power of GWASs is too low to detect common alleles that contribute only minutely to a disease. Now, Voight et al. (2010) demonstrate that a valuable strategy for improving the statistical power of GWASs is to combine the results of previous experiments into one large meta-analysis. Indeed, by merging the data from the previous eight GWASs, the authors identify 12 new polymorphisms linked to type 2 diabetes and increase the total number of disease loci by a whopping 50%. Moreover, these new polymorphisms include the first association of type 2 diabetes with the X chromosome and seven loci that overlap with regions already connected to other phenotypes, such as basal cell carcinoma and high cholesterol. To characterize the physiological relevance of all 38 common variants linked to type 2 diabetes, Voight et al. correlated the genotype data with clinical observations. Ten loci were associated with reduced function of the pancreatic beta cells that produce insulin, whereas three loci were correlated with reduced insulin sensitivity. Although the polymorphisms identified in the study do not illuminate the specific genes and molecular processes underlying an individual's risk for developing type 2 diabetes, these results do pinpoint promising hotspots in the genome where such information lies. Future sequencing and fine-mapping of these regions will hopefully light the path to stopping this growing worldwide epidemic. B.F. Voight et al. (2010) . Nat. Genet. 42, [579] [580] [581] [582] [583] [584] [585] [586] [587] [588] [589] Working Together, SNPs Reach New Heights If pooling data from multiple studies increases the power of GWASs to detect risk alleles, could pooling the polymorphisms increase the heritability accounted for by common variants? Conventional GWASs calculate how much each allele individually contributes to the total variation in a given phenotype (i.e., its effect size). If the effect of a polymorphism is below a statistical threshold, then the variant is dismissed as insignificant and overlooked as a player in the etiology of the disease. However, if these small contributors are analyzed together, their total impact on a given phenotype may be large enough to pass even very stringent statistical tests typically used in GWASs. Indeed, Yang et al. (2010) report that for human height, a big chunk of the ''genetic dark matter'' is hidden in a slew of common variants that never reached statistical significance in previous GWASs (i.e., false negatives). Three previous GWASs with more than 10,000 individuals identified 50 common variants associated with height, but these polymorphisms accounted for only 6% of height heritability. In contrast, when Yang et al. simultaneously fit all of the common polymorphisms, which included 295,000 SNPs, they find that together these common alleles explain 56% of the genetic factors contributing to height. So what about the other 44%? A series of calculations and simulations suggest that this discrepancy may be largely because polymorphisms genotyped in GWASs and the nucleotide variations that actually determine a person's height are not always inherited together. When they take this ''incomplete linkage disequilibrium'' into account, the common polymorphisms identified by GWASs explain almost 67% of height heritability. Could the remaining genetic factors arise from rare structural variations in the human genome that are not correlated with GWAS SNPs? J. Yang et al. (2010) . Nat. Genet. 42, 565-569.
Think Structure, Not Sequence
Although conventional GWASs focus only on single-nucleotide differences between individuals, a hefty portion of the diversity in the human genome originates from structural variations in which entire genes or genomic regions are deleted, duplicated, or rearranged. Now, Pinto et al. (2010) present evidence that these so-called ''copy-number variants'' (CNVs) may account for a substantial amount of the heritability underlying autism spectrum disorder, a condition characterized by abnormal social interactions and sometimes cognitive dysfunction. Moreover, the authors use these rare structural variations to generate the first functional map of biological pathways potentially disrupted in autistic individuals. Genetics plays a key role in autism spectrum disorder, but previous GWASs identified only two common polymorphisms associated with a small increased risk for the disease. To uncover rare structural variations linked with autism, Pinto et al. scanned the genome of 996 individuals with autism and used microarrays to compare their CNVs with those of their parents and 1300 controls. With new algorithms and stringent ''quality control'' criteria, Pinto et al. pinpointed 5500 rare CNVs R30 kb in size that occurred with a frequency of <1%. Although the total number of these structural variations per person is the same across all three groups, individuals with autism surprisingly carry 26% more gene deletions (or partially gene deletions) than their parents and the controls. Each specific deletion is quite rare, appearing in only a few patients; however, the genes disrupted often function in similar biological pathways, including those involved with intellectual disabilities. For example, many of the gene deletions affect neuronal development, proliferation, motility, and signaling by GTPase/ Ras components. These results suggest that each person with autism likely carries his own unique set of ''autism'' loci; however, the biological processes impacted by these genomic rearrangements will probably be similar for many individuals. D. Pinto et al. (2010) . Nature. Published online June 9, 2010 June 9, . 10.1038 
Rearranging Our View on Gene Dosage
In contrast to autism spectrum disorder, for which no single gene or even a specific group of genes usually underlies the disease, the genetic origins of Charcot-Marie-Tooth disease type 1A and HNPP (hereditary neuropathy with liability to pressure palsies) are relatively clear. Either a duplication or a deletion of a 1.4 Mb segment near the gene encoding peripheral myelin protein (PMP22) leads to these incurable nerve disorders. Now, a study by Zhang et al. (2010) shows that, even in relatively clear-cut cases such as these, an unexpectedly diverse array of rare genomic rearrangements can cause the same disease. Moreover, these rare structural variations do not need to occur within PMP22 to alter its expression and cause neuropathy. Using a genomic hybridization technique in combination with high-resolution microarrays, Zhang et al. identified 17 unique structural variations within or near the PMP22 gene from 21 patients with Charcot-Marie-Tooth disease type 1A or HNPP. Half of these rare genomic rearrangements did not alter the integrity of the PMP22 gene but instead changed its total copy number by deleting, duplicating, or even triplicating the PMP22 gene. Interestingly, one patient possessed a duplication of a 194 kb segment upstream of the PMP22 coding region. The diverse size, location, and content of the structural variations uncovered for even this tiny section of the genome underscores the daunting challenge in identifying rare variations in copy number for genome-wide studies on complex diseases. F. Zhang et al. (2010) . Am. J. Hum. Genet. 86, [892] [893] [894] [895] [896] [897] [898] [899] [900] [901] [902] [903] Heritability Hide-and-Seek Taken together, the four articles highlighted in this Select suggest that for certain diseases and phenotypes, the heritability is not ''missing'' but simply hiding below the statistical threshold of standard GWASs. In contrast, for other traits, a large portion of the heritability resides in rare structural variations-similar to those described for Charcot-Marie-Tooth disease and autism spectrum disorder-that require new techniques and methods to observe. Can we predict a priori in which category a disease or trait will fall? Enter Park et al. (2010) , who use existing GWAS data to estimate the expected number of additional disease loci that future GWASs will uncover. Furthermore, their statistical method calculates both the sample size required to detect these new variants and the power these alleles have for predicting an individual's risk for a disorder. For example, the authors estimate that for Crohn's disease, 142 additional susceptibility loci are detectable in a GWAS with 25,000 patients and controls. Furthermore, these common polymorphisms together will explain 20% of the heritability of this inflammatory bowel disorder. In contrast, for breast, prostate, and colorectal cancers, Park et al. estimate that only 67 additional loci are required on average to explain 17% of the genetic factors for each cancer. Although these calculations indicate that larger GWASs or meta-analyses will indeed uncover many more susceptibility alleles for these complex diseases, the results of this analysis also indicate that >50% of the heritability will still be ''missing.'' Thus, at least for most chronic illnesses, the hunt for heritability will continue for many years to come. J.H. Park et al. (2010) . Nat. Genet. 42, [570] [571] [572] [573] [574] [575] .
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